Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

NCT07386704 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer Non-resectable

Interventions

DRUG: Nimotuzumab combined with chemoradiotherapy

Sponsor

Peking University First Hospital